Sundown Syndrome in Older Persons: A Scoping Review

Carregando...
Imagem de Miniatura
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
BORONAT, Alexandre C.
WANG, Yuan-Pang
Citação
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, v.20, n.6, p.664-+, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: To map comprehensive investigations of the sundown syndrome (SS), highlighting its key definition and associated characteristics. Design: Scoping review of published articles on SS in PubMed, OVID, EMBASE, Scopus, CINAHL, and Science Direct. Setting: Post-acute and long-term health care settings. Participants: Older adults aged >= 60 years. Measures: Articles must present primary data on specific SS behavior, with explicit psychopathological and quantitative outcomes; and/or evening disruptive behavior. Results: From a total number of 460 articles focusing on psychopathology and standardized outcomes of SS, 23 were retained for the final analysis (n = 1210 subjects). The mean age of participants was 63.2 years, and slightly more participants were women. The samples were recruited by convenience from long-term care facilities and tertiary outpatient clinics. The frequency of SS varied from 2% to 82%, without evident difference between genders and race/ethnicity. Generally, the sundown episode occurred during later daytime, when psychomotor alterations and cognitive disturbance manifested repeatedly. The symptomatic manifestations of SS were heterogeneous across the studies. Demographic risk factors were inconsistent. Although some authors have viewed cognitive impairment as a substantive predisposing factor to SS, others supported SS as a predictor of looming cognitive decline. The disrupted circadian rhythm was the most accepted pathophysiology. To date, clinical trials to guide the management of SS with specific pharmacologic and nonpharmacologic approaches are scant. Conclusions and Implications: SS can be viewed as a cyclic delirium-like condition affecting the older population around the sunset hour that may last for a few hours. The scarcity of comprehensive studies makes it difficult to determine whether and to what extent it can represent a distinct disease, a prodromal stage of dementia, or an epiphenomenon of incipient or worsening dementia. Extensive gathering of clinical data from multiple health care settings, using uniform measurement tools, is much needed. (C) 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
Palavras-chave
Sundown syndrome, dementia, cognitive impairment, disruptive behaviors, circadian rhythm
Referências
  1. American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS
  2. Sevilla DA, 2018, J ALZHEIMERS DIS, V62, P335, DOI 10.3233/JAD-170488
  3. Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI 10.1080/1364557032000119616
  4. Asayama Kentaro, 2003, Journal of Nippon Medical School, V70, P334
  5. Avidan AY, 2006, SLEEP MED CLIN, V1, P273, DOI 10.1016/j.jsmc.2006.04.010
  6. Bachman D, 2006, ANNU REV MED, V57, P499, DOI 10.1146/annurev.med.57.071604.141451
  7. Bedrosian TA, 2013, EXP NEUROL, V243, P67, DOI 10.1016/j.expneurol.2012.05.005
  8. BLIWISE DL, 1995, J GERIATR PSYCH NEUR, V8, P107, DOI 10.1177/089198879500800206
  9. BLIWISE DL, 1993, PSYCHIAT RES, V48, P277, DOI 10.1016/0165-1781(93)90078-U
  10. Bliwise Donald L, 2004, Clin Cornerstone, V6 Suppl 1A, pS16, DOI 10.1016/S1098-3597(04)90014-2
  11. Cameron DE, 1941, PSYCHIAT QUART, V15, P47, DOI 10.1007/BF01613953
  12. Cammisuli DM, 2016, EUR GERIATR MED, V7, P57, DOI 10.1016/j.eurger.2016.01.002
  13. Campbell N, 2008, CLIN INTERV AGING, V3, P719
  14. Canevelli M, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00073
  15. Chen R, 2012, J NEUROIMMUNOL, V244, P97, DOI 10.1016/j.jneuroim.2011.12.015
  16. Cipriani G, 2015, EUR GERIATR MED, V6, P375, DOI 10.1016/j.eurger.2015.03.006
  17. Cohen-Mansfield J, 2000, ARCH GERONTOL GERIAT, V31, P65, DOI 10.1016/S0167-4943(00)00068-6
  18. Cohen-Mansfield J, 2007, AM J GERIAT PSYCHIAT, V15, P395, DOI 10.1097/01.JGP.0000247162.59666.68
  19. Colquhoun HL, 2014, J CLIN EPIDEMIOL, V67, P1291, DOI 10.1016/j.jclinepi.2014.03.013
  20. Drake L, 1997, Nurs Stand, V12, P37
  21. DUCKETT S, 1992, Brain Injury, V6, P189, DOI 10.3109/02699059209029658
  22. DUCKETT S, 1993, J REHABIL, V59, P24
  23. Duncan MJ, 2013, EXP NEUROL, V243, P1, DOI 10.1016/j.expneurol.2013.02.003
  24. EVANS LK, 1987, J AM GERIATR SOC, V35, P101, DOI 10.1111/j.1532-5415.1987.tb01337.x
  25. EXUM ME, 1993, GERONTOLOGIST, V33, P756, DOI 10.1093/geront/33.6.756
  26. Foley D, 1999, LANCET, V354, P2098, DOI 10.1016/S0140-6736(99)00413-4
  27. GALLAGHERTHOMPSON D, 1992, J AM GERIATR SOC, V40, P807, DOI 10.1111/j.1532-5415.1992.tb01853.x
  28. Gehrman PR, 2009, AM J GERIAT PSYCHIAT, V17, P166, DOI 10.1097/JGP.0b013e318187de18
  29. Gnanasekaran G, 2016, AGING CLIN EXP RES, V28, P383, DOI 10.1007/s40520-015-0431-3
  30. GOUDSMIT E, 1992, PROG BRAIN RES, V93, P237
  31. Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x
  32. Haro MDN, 2011, 7 C EUGMS EUR GER ME, V2S, pS65
  33. Khachiyants N, 2011, PSYCHIAT INVEST, V8, P275, DOI 10.4306/pi.2011.8.4.275
  34. Kunz D, 1999, NEUROPSYCHOPHARMACOL, V21, P765, DOI 10.1016/S0893-133X(99)00069-X
  35. Lammers M, 2013, J AM GERIATR SOC, V61, P1045, DOI 10.1111/jgs.12296
  36. Lebert F, 1996, ARCH GERONTOL GERIAT, V22, P49, DOI 10.1016/0167-4943(95)00676-1
  37. Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69
  38. LITTLE JT, 1995, J GERIATR PSYCH NEUR, V8, P103, DOI 10.1177/089198879500800205
  39. LOVELL BB, 1995, PSYCHIAT RES, V57, P7, DOI 10.1016/0165-1781(95)02550-G
  40. Lungu O, 2015, ALZHEIMERS DEMENT, V11, P787
  41. Marcantonio ER, 2017, NEW ENGL J MED, V377, P1456, DOI 10.1056/NEJMcp1605501
  42. Martin J, 2000, CHRONOBIOL INT, V17, P405, DOI 10.1081/CBI-100101054
  43. McArthur AJ, 1996, SLEEP, V19, P544, DOI 10.1093/sleep/19.7.544
  44. Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050
  45. Pham MT, 2014, RES SYNTH METHODS, V5, P371, DOI 10.1002/jrsm.1123
  46. SAGHIR MT, 1970, AM J PSYCHIAT, V126, P1079
  47. Scarmeas N, 2007, ARCH NEUROL-CHICAGO, V64, P1755, DOI 10.1001/archneur.64.12.1755
  48. Shih YH, 2017, J AM MED DIR ASSOC, V18, P396, DOI 10.1016/j.jamda.2016.10.016
  49. Singer C, 2003, SLEEP, V26, P893, DOI 10.1093/sleep/26.7.893
  50. SPITZER RL, 1983, COMPR PSYCHIAT, V24, P399, DOI 10.1016/0010-440X(83)90032-9
  51. Subhadeep D, 2017, PHYSIOL BEHAV, V170, P124, DOI 10.1016/j.physbeh.2016.11.040
  52. Sullivan E M, 1991, AORN J, V53, P824, DOI 10.1016/S0001-2092(07)68960-1
  53. Sullivan EM, 1991, AORN J, V53, P824
  54. Sullivan EM, 1991, AORN J, V53, P822
  55. Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850
  56. Tricco AC, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0116-4
  57. Venturelli M, 2013, J AM GERIATR SOC, V61, P2055, DOI 10.1111/jgs.12491
  58. Volicer L, 2001, AM J PSYCHIAT, V158, P704, DOI 10.1176/appi.ajp.158.5.704
  59. Wallace M, 1994, Geriatr Nurs, V15, P164
  60. Wu YH, 2005, J PINEAL RES, V38, P145, DOI 10.1111/j.1600-079X.2004.00196.x
  61. Yevchak AM, 2012, RES GERONTOL NURS, V5, P294, DOI 10.3928/19404921-20120906-04